July 1, 2022: Lab Water Solutions from Merck is introducing an international platform to connect the industry with global industry experts to learn how to build ‘Next-Gen Labs’ and usher in an era of innovation and sustainability.
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live.
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July, 11 am IST (13.30 SGT). The event would be attended by many researchers and scientists from across the industries in South APAC.
Renowned industry experts from various countries would be joining the virtual conclave as speakers, like, Eugene Wang, Co-Founder and CEO, Sophie’s BioNutrients, Singapore, Priyanka Chamoli, Director- QA, Avance Clinical, Australia, Branka Knezevic, Head of Sales & Service, Lab Water, Australia & New Zealand, Merck to name a few.
As labs across the world enter a new era of Digital Transformation and Artificial Intelligence, the requirements of the ‘Labs of Tomorrow’ will be markedly different from those of today. An evolving regulatory landscape and increasing amount of data being generated, the role of digitization and data analytics is critical to attain peak productivity. As a global leader, the Merck is leading the industry by taking an initiative to develop a high-level view of the Future of Labs – those that are connected, innovative and more sustainable.
This event will help participants to prepare for this journey and discuss about:
- Key trends shaping the labs of the future
- Technologies and digital solutions driving productivity
- Compliance with regulatory needs
- Steps to build sustainable labs to optimize resources and accelerating research
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck generated sales of € 19.7 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.